Premium
Effects of tibolone on the quality of life, anxiety‐depression levels and cognitive functions in natural menopause: An observational follow‐up study
Author(s) -
GÜLSEREN Leyla,
KALAFAT Devrim,
MANDACI Hatice,
GÜLSEREN Şeref,
ÇAMLI Lütfü
Publication year - 2005
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.1479-828x.2005.00345.x
Subject(s) - tibolone , anxiety , observational study , menopause , depression (economics) , quality of life (healthcare) , cognition , medicine , mental health , clinical psychology , psychiatry , psychology , nursing , economics , macroeconomics
The effects of tibolone on the quality of life (QoL), depression‐anxiety levels and cognitive functions were investigated. Seventeen women received tibolone and 25 women did not receive any medication. At the end of the 6‐month follow‐up period, the QoL was better in the tibolone group in the area of mental health. Disability, anxiety symptoms, menopausal symptoms were significantly reduced in this group.